On Monday, AbbVie Inc (NYSE:ABBV)’s shares inclined 6.42% to $63.38.
AbbVie Inc (ABBV) has the market capitalization of $98.56 billion. The stock has P/B ratio of -18.64 while EPS was $1.28. Institutional ownership of the company was 75.10% while 1.66 billion shares were outstanding. Net profit margin of the Company was 9.90% while its gross profit margin was 80.70%. Share of the company moved above its SMA 50 with 11.09%. ROE ratio was 62.80% while ROI was 16.80%.
AbbVie Inc. (AbbVie) is a global, research-based biopharmaceutical company. The Company develops and markets therapies that address a range of diseases.
American International Group Inc (NYSE:AIG)’s shares gained 1.03% to $63.71.
American International Group Inc (AIG) Its past 5-day performance at 3.98%. So far in 2015, the company has a year-to-date performance of 13.8%. The stock, as of last close, traded 32.14% up from its 52 week low and was -1.35% below its 52 week high. Its latest closing price was 9.66% above the SMA200 while the distance from SMA 50 and SMA 20 was 8.34% and 6.25% respectively.
American International Group, Inc. (AIG) is an insurance company. The Company provides a range of property casualty insurance, life insurance, retirement products, mortgage insurance and other financial services.
At the end of Monday’s trade, TherapeuticsMD Inc (NYSEMKT:TXMD)‘s shares surged 9.20% to $6.41.
TherapeuticsMD Inc (TXMD) has market capitalization of $1.04 billion. Its current ratio was 6.20 while its shares were above its 50 days simple moving average with 1.70%. The company offered earning per share of $-0.51 while its 177.50 million shares were outstanding. YTD performance of the company was 44.04%. Stock volatility for the week was 8.42% while for the month it was shown at 7.07%.
TherapeuticsMD, Inc. is a women’s health care product company. The Company is engaged in creating and commercializing products for women. The Company is focused on conducting clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.